The consensus estimate was a loss of $0.27 per share on revenue of $55.2 million. Non-U.S. GAAP measures exclude significant expenses that are required by U.S. GAAP to be recorded in the Company's financial statements and are subject to inherent limitations. The increase was primarily due to a one-time Bulk transaction associated with the termination of a supply contract. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only.
These protocols are being evaluated and adapted in accordance with government and health authority recommendations on a daily basis. The Earnings Whisper number was for a loss of $0.34 per share. Tilray (Nasdaq: TLRY) is a global pioneer in the research, cultivation, production and distribution of cannabis and cannabinoids currently serving tens of thousands of patients and consumers in 15 countries spanning five continents. Gross margin, excluding inventory valuation adjustments reconciliation: Gross profit, excluding inventory valuation adjustments, Gross margin, excluding inventory valuation adjustments, View source version on businesswire.com: https://www.businesswire.com/news/home/20200511005877/en/, For further information: The Algorithm predicts "% Predicted Move After Earnings Announcement" (PMAEA) for TLRY three weeks prior to earnings date.
Información sobre tu dispositivo y conexión a Internet, incluida tu dirección IP, Actividad de navegación y búsqueda al utilizar sitios web y aplicaciones de Verizon Media.
Cannabis stocks have found a bottom, and Tilray (NASDAQ:TLRY) is no exception.
Non-U.S. GAAP measures exclude significant expenses that are required by U.S. GAAP to be recorded in the Company's financial statements and are subject to inherent limitations.
Shares are down 21.1% since reporting last quarter. Tilray, Inc. (NASDAQ:TLRY)’s Major holders. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, including assumptions in respect of current and future market conditions. “We remain focused on executing on our long-term growth opportunities and our goal of generating positive Adjusted EBITDA by the end of the fourth quarter. 2020 InvestorPlace Media, LLC. While the positive impact of these actions are not fully reflected in this quarter’s results, they will become more clearly evident over the course of this year.”. Please see the heading “Risk Factors” in Tilray’s Quarterly Report on Form 10-Q, which was filed with the Securities and Exchange Commission on August 10, 2020, for a discussion of the material risk factors that could cause actual results to differ materially from the forward-looking information.
So far, 2020 hasn't been pretty either for Tilray stock.
To date, the Company has not experienced any material COVID-19 impacts related to its ability to serve patients and consumers around the world with medical cannabis products, adult-use cannabis products in Canada, and Manitoba Harvest hemp products. Adjusted EBITDA is calculated as net income(loss) before inventory valuation adjustments; interest expenses, net; other expenses (income), net; deferred income tax (recoveries) expenses, current income tax expenses (benefit); foreign exchange gain (loss), net; depreciation and amortization expenses; stock-based compensation expenses; other stock-based compensation related expenses; loss from equity method investments; finance income from ABG; loss on disposal of property and equipment; acquisition-related (income) expense; amortization of inventory step-up; severance costs; impairment of assets; and change in fair value of warrant liability. Those trends aren’t yet improving.
Intraday data delayed at least 15 minutes or per exchange requirements. Para permitir a Verizon Media y a nuestros socios procesar tus datos personales, selecciona 'Acepto' o selecciona 'Gestionar ajustes' para obtener más información y para gestionar tus opciones, entre ellas, oponerte a que los socios procesen tus datos personales para sus propios intereses legítimos. Meanwhile, Cronos (NASDAQ:CRON) and Canopy Growth (NYSE:CGC) have billions of dollars in cash that they can use to take share and drive innovation.
The deficit was a little over $3 million in 2016 — and $258 million last year. Investors interested in participating in the live call can dial 877-489-6528 from the U.S. and 629-228-0736 internationally. Tilray Stock Is a Loser in the Cannabis World, Matt McCall and the InvestorPlace Research Staff, Click here to see what Matt has up his sleeve now, The 7 Best Semiconductor Stocks to Buy Today, Louis Navellier and the InvestorPlace Research Staff, Trump vs. Biden: Stocks to Buy No Matter Who Wins the White House, SPI Stock News: Why SPI Energy Is Surging 700% Today, 7 5G Stocks for the Next Communication Revolution, 10 Stocks For Beginners To Buy Today For Profits Tomorrow, The Holes in the Bull Case for Workhorse Stock, Buy Exxon Mobil Stock While It’s Still Deeply Unpopular.
The Company will host a conference call today, August 10, 2020, to discuss these results at 5:00 p.m.